Slide 1: Analyst / Investor Conference Call Q3 2012 Results
Analyst / Investor Conference Call Q3 2012 Results October 4, 2012 3:00 p.m. CEST Uwe Röhrhoff, CEO Jürgen Wiecha, CFO
Slide 2: Disclaimer
Disclaimer This presentation may contain certain forward-looking statements, including assumptions, opinions and views of the Company or cited from third party sources. Various known and unknown risks, uncertainties and other factors could cause the actual results, financial position, development
Slide 3: Agenda
Agenda Review Q3 2012 and Guidance FY 2012 Uwe Röhrhoff, CEO Financial Overview Q3 2012 Jürgen Wiecha, CFO Appendix 3
Slide 4: Q3 2012: Key figures confirm healthy growth trend
Q3 2012: Key figures confirm healthy growth trend Key group figures in EUR m, EPS in EUR Revenues adjusted EBITDA FXN: + 6.3% adjusted EBITDA Margin + 9.2% + 6.5% 20.0% 19.5% adjusted EPS Net Financial Debt - 11.4% + 9.8% 4
Slide 5: Q3 2012: Growth driven by all divisions
Q3 2012: Growth driven by all divisions Tubular Glass: Revenue growth and margin impacted by insufficient productivity in RTF®-syringe business Adjusted EBITDA margin improved quarter-on-quarter Plastic Systems: Good revenue growth driven by inhalation device business and primary pharmaceu
Slide 6: Confirmation of FY 2012 guidance
Confirmation of FY 2012 guidance FY 2011 Original Guidance Updated Guidance3 Confirmed Guidance3 as reported FY 2012 FY 2012 FY 2012 as of Feb. 8, 2012 as of Apr. 12, 2012 as of Oct. 4, 2012 + 5% to 6% at const. FX + 7% to 8% at const. FX + 9% to 10% at const. FX Revenues EUR 1,094.7m1 + 7% to 8% no
Slide 7: Agenda
Agenda Review Q3 2012 and Guidance FY 2012 Uwe Röhrhoff, CEO Financial Overview Q3 2012 Jürgen Wiecha, CFO Appendix 7
Slide 8: Q3 2012 P&L Overview
Q3 2012 P&L Overview Q3 2012 Q3 2011 Change EUR m EUR m in % Revenues 311.4 285.1 +9.2 Adjusted EBITDA1 60.8 57.1 +6.5 EBITA 35.6 36.1 -1.4 Profit before interest and taxes (EBIT) 30.9 31.4 -1.6 Financial result -9.0 -8.0 -12.5 Profit before taxes 21.9 23.4 -6.4 Net income 14.4 19.2 -25.0 EPS in EUR
Slide 9: Q3 2012: Revenues by division
Q3 2012: Revenues by division Q3 2012 Change Change in % at EUR m in % const. FX Total Group 311.4 +9.2 +6.3 Tubular Glass 84.6 +10.9 +3.5 Plastic Systems 107.0 +3.5 +5.8 Moulded Glass 95.6 +11.6 +9.2 Life Science Research 27.7 +17.9 +3.7 9
Slide 10: Q3 2012: Adjusted EBITDA and margin by division
Q3 2012: Adjusted EBITDA1 and margin by division Q3 2012 Q3 2011 Change Margin Margin EUR m in % in % in % Total Group 60.8 +6.5 19.5 20.0 Tubular Glass 17.0 +9.6 20.2 20.4 Plastic Systems 22.0 -5.6 20.5 22.5 Moulded Glass 22.5 +12.7 23.6 23.3 Life Science Research 3.8 +23.6 14.0 13.3 1 Earnings bef
Slide 11: Key balance sheet figures
Key balance sheet figures August 31, 2012 August 31, 2011 Change EUR m EUR m in % Equity 559.4 550.7 +1.6 Equity ratio in % 36.5 37.5 Net Working Capital1 220.1 187.5 +17.4 in % of LTM revenues 18.6 17.4 Net Financial Debt2 413.4 376.4 +9.8 Adj. EBITDA Leverage 1.9 1.8 +5.6 Q3 2012 Q3 2011 Change EU
Slide 12: Long-term financing structure with ample financial leeway
Long-term financing structure with ample financial leeway Comparison of debt/cash positions in EUR m Net Financial Debt 376.4 413.4 Interest rate (due date): Bond 300.0 300.0 Fixed coupon at 5.0% (2018) Interest rate hedged at 3.26% Long-term bank debt 143.6 139.9 (2016) 0.0 Revolving bank debt 30.0
Slide 13: Financial Calendar
Financial Calendar February 14, 2013 Annual Report 2012 April 10, 2013 Interim Report 1st Quarter 2013 April 18, 2013 Annual General Meeting 2013 July 10, 2013 Interim Report 2nd Quarter 2013 October 2, 2013 Interim Report 3rd Quarter 2013 13
Slide 14: Investor Relations & Creditor Relations contact details
Investor Relations & Creditor Relations contact details Phone +49 211 6181-257 Fax +49 211 6181-121 E-mail gerresheimer.ir@gerresheimer.com IR website www.gerresheimer.com/ir 14
Slide 15: Agenda
Agenda Review Q3 2012 and Guidance FY 2012 Uwe Röhrhoff, CEO Financial Overview Q3 2012 Jürgen Wiecha, CFO Appendix 15
Slide 16: Third quarter reconciliation from adjusted EBITDA to net income
Third quarter reconciliation from adjusted EBITDA to net income Q3 2012 Q3 2011 EUR m EUR m Adjusted EBITDA 60.8 57.1 One-off income/expense -1.5 -0.4 EBITDA 59.3 56.7 Amortization of fair value adjustments 4.7 4.7 Depreciation and amortization 21.1 20.6 Impairment loss 2.6 0.0 Profit before interes
Slide 17: Q1-Q3 2012 P&L Overview
Q1-Q3 2012 P&L Overview Q1-Q3 2012 Q1-Q3 2011 Change EUR m EUR m in % Revenues 894.2 806.3 +10.9 Adjusted EBITDA1 163.7 155.1 +5.5 EBITA 94.6 92.5 +2.3 Profit before interest and taxes (EBIT) 81.2 78.4 +3.6 Financial result -24.2 -28.2 +14.2 Profit before taxes 57.0 50.2 +13.5 Net income 38.6 39.4 -
Slide 18: Q1-Q3 2012: Revenues by division
Q1-Q3 2012: Revenues by division Q1-Q3 2012 Change Change in % at EUR m in % const. FX Total Group 894.2 +10.9 +9.1 Tubular Glass 246.0 +9.3 +4.8 Plastic Systems 310.3 +13.5 +15.2 Moulded Glass 271.2 +8.0 +6.4 Life Science Research 77.3 +13.3 +4.4 18
Slide 19: Q1-Q3 2012: Adjusted EBITDA and margin by division
Q1-Q3 2012: Adjusted EBITDA1 and margin by division Q1-Q3 2012 Q1-Q3 2011 Change Margin Margin EUR m in % in % in % Total Group 163.7 +5.5 18.3 19.2 Tubular Glass 46.7 +1.0 19.0 20.6 Plastic Systems 64.8 +6.0 20.9 22.4 Moulded Glass 57.1 +5.4 21.1 21.6 Life Science Research 9.8 +18.3 12.7 12.2 1 Ear
Slide 20: Q1-Q3 2012 reconciliation from adjusted EBITDA to net income
Q1-Q3 2012 reconciliation from adjusted EBITDA to net income Q1-Q3 2012 Q1-Q3 2011 EUR m EUR m Adjusted EBITDA 163.7 155.1 One-off income/expense -4.7 -1.8 EBITDA 159.0 153.3 Amortization of fair value adjustments 13.4 14.1 Depreciation and amortization 61.8 60.8 Impairment loss 2.6 0.0 Profit befor